导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -2.22% | 621/1050 |
| 近一周 | -2.17% | 477/1104 |
| 近一月 | -5.59% | 667/1102 |
| 近一季 | -5.40% | 435/1092 |
| 近半年 | -7.68% | 697/1070 |
| 近一年 | 3.89% | 493/1018 |
| 近两年 | 34.85% | 639/926 |
| 近三年 | 18.03% | 514/834 |
| 成立以来 | 247.50% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.13% 565/1070 |
9.46% 553/1101 |
- - |
- - |
| 2025 | 16.89% 724/1065 |
2.81% 561/1014 |
0.07% 676/1038 |
11.98% 808/1050 |
1.45% 351/1065 |
| 2024 | 11.79% 247/1011 |
6.41% 73/960 |
-0.52% 340/983 |
6.85% 826/991 |
-1.16% 393/1011 |
| 2023 | 11.90% 19/952 |
20.50% 26/880 |
2.07% 98/895 |
-2.83% 195/915 |
-6.38% 628/952 |
| 2022 | -20.43% 342/867 |
-18.58% 451/773 |
1.26% 674/806 |
-11.61% 358/845 |
9.20% 92/867 |
| 2021 | 20.20% 155/740 |
4.60% 52/580 |
7.34% 423/659 |
0.68% 208/704 |
6.33% 169/740 |
| 2020 | 46.17% 261/554 |
-4.55% 276/419 |
12.73% 380/466 |
20.38% 54/517 |
12.84% 258/554 |
| 2019 | 28.81% 296/410 |
14.04% 1016/1146 |
3.59% 87/1228 |
0.54% 322/390 |
8.45% 221/410 |
| 2018 | -16.38% 37/349 |
- - |
-1.50% 103/990 |
-2.84% 362/1000 |
-11.25% 433/1080 |
| 2017 | 31.98% 33/285 |
- - |
- - |
- - |
- - |
| 2016 | 11.34% 6/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 诺安先进制造股票A VS. 东吴新产业精选股票A(580008) |